Submission Information


SUBMISSIONS ARE NOW CLOSED

Oral and Poster Presentation Information Forthcoming

Join Over 2,500+ International Delegates at ISCT 2024 Vancouver to Gain Unparalleled Exposure for Your Research.


Present and Network with Decision-Makers Including C-Suite, Directors, and Managers of Leading Organizations and Labs in the Global Cell and Gene Therapy Space.

ISCT 2024 Vancouver will feature a large Poster Hall open to delegates throughout the meeting.

In addition, ISCT will host two dedicated poster networking receptions during which all meeting delegates gather in the Poster Hall to review research, discuss findings and network with presenters.

48 high-scoring abstracts will be invited to give a 10-minute presentation of their work at one of the 8 oral abstract sessions. 

Oral abstract sessions are well-attended attracting over 200 delegates.

Thirty high-scoring abstracts will be invited to present their abstract as an elevator pitch and compete for the Best Elevator Pitch Award.

Presenters will have 2 minutes to summarize their research and its impact on the field.

WHY PRESENT AT ISCT 2024?

A Truly Translational Focus on a Global Platform
Whether you focus on basic science and preclinical studies, clinical investigations, manufacturing, regulatory, quality, policy, ethics, or commercialization, your work is vital to advancing the field of cell and gene therapy. ISCT is the place for you to discuss your research with a global community of experts across the translation field.    

Showcase Your Research  - Get Feedback, Collaborate
Be considered for an oral abstract, elevator pitch presentation, or poster presentation and promote your work to global leaders in the cell and gene therapy sector.  Gain exposure to key opinion leaders, potential collaborators, future employers, and expand your professional network.   

Publish Your Work
Accepted abstracts will be published in a special supplement of Cytotherapy, the official journal of ISCT.  With a 5-year Impact Factor of 5.0 and a global readership, Cytotherapy represents an excellent platform to highlight your work to a translational audience. Many studies first presented at ISCT Annual Meetings go on to be published as full-length articles.

Qualify for Awards
ISCT recognizes outstanding abstracts and presentations. AT ISCT 2023 Paris, 15 winners were awarded a combined total of $16,000. Submit an abstract and join ISCT to qualify!

Launch Your Career
ISCT is invested in the future of our sector and has created exclusive opportunities for Early Stage Professionals to present their work at ISCT 2024. Students, recent grads, and postdocs are encouraged to submit.

KEY DATES


ACCEPTED ABSTRACT RSVP AND REGISTRATION DEADLINE
March 12, 2024 

LATE BREAKING ABSTRACT NOTIFICATIONS
March 26, 2024

LATE BREAKING REGISTRATION AND RSVP DEADLINE
April 9, 2024

ABSTRACT CATEGORIES

  • Mesenchymal Stem/Stromal Cells
  • Hematopoietic Stem/Progenitor Cells and Engineering
  • Immunotherapy (CAR-T, T Reg, NK Cells etc.)
  • Exosomes/EVs
  • iPSC
  • Gene Editing/Gene Therapy
  • Tissue Engineering
  • Embryonic, Organ and Other Tissue Specific Stem Cells
  • Process Development and Manufacturing
  • Regulatory Affairs, Quality Systems, Policy and Ethics


Full List of Abstract Categories

ABSTRACT AWARDS

General eligibility criteria:

  1. Recipient must hold current 2024 ISCT membership.
  2. Recipient must present the abstract in-person at ISCT 2024 Vancouver.
  3. Recipient cannot win multiple awards.

1 Available | Sponsor: Cytotherapy

The Top Scoring Abstract Award recognizes outstanding abstract submissions across the field of cell and gene therapy translation. This award is given to the abstract receiving the top score through our blinded-review process.

  • Specific Eligibility Criteria: None

1 Available | Sponsor: BioCentriq Inc.

The Best Poster Award is voted on by the ISCT 2024 Vancouver Planning Faculty. It recognizes the best poster being presented in terms of the quality of the research and the quality of the display and messaging.

  • Specific Eligibility Criteria: Recipient must present a poster at ISCT 2024 Vancouver.

1 Available | Sponsor: Cytotherapy

The ISCT 2024 Organizing Committee will attend the Elevator Pitch Competition and vote on the presentation that most effectively communicates a concise and comprehensive overview of the presenter's research within the alloted two minutes.

  • Specific Eligibility Criteria: Recipient must be an invited participant in the Elevator Pitch Competition.

3 Available | Sponsor: ISCT

The Early Stage Professionals Awards recognize outstanding research submitted by Early Stage Professionals.

  • Specific Eligibility Criteria: Presenter must be an Early Stage Professional. Early Stage Professionals are classified as students or professionals within ten years of their terminal degree or entry into the field of cell and gene therapy.

3 Available | Sponsor: ISCT

ISCT recognizes that research and innovation begins at "the bench" and have established the Technologist Awards to celebrate impactful submissions from laboratory technicians.

  • Specific Eligibility Criteria: Recipient must be a laboratory technician and be employed in technical laboratory settings (laboratory directors and upper management are not eligible). Laboratory technicians typically hold a technical designation (e.g., MLS(ASCP) or equivalent).

1 Available | Sponsor: Cytotherapy

The Emerging Economy Abstract Award is granted to the top scoring abstract being presented by an author residing in a developing economy.

  • Specific Eligibility Criteria: Recipient must reside in a low-income or middle-income economy (LMIC) as defined by the World Bank.

1 Available | Sponsor: Cytotherapy

The Early Stage Professional Rookie of the Year Award recognizes an outstanding abstract from an Early Stage Professional presenting for the first time at an ISCT conference. 

  • Specific Eligibility Criteria: Presenter must be an Early Stage Professional presenting an abstract at an ISCT meeting for the first time. Early Stage Professionals are classified as students or professionals within ten years of their terminal degree or entry into the field of cell and gene therapy.

10 Available | Sponsor: ISCT

Recognizing the breadth and depth of local research, these awards provide a platform to showcase work being performed in Canada to a global audience, and offer an opportunity for local researchers to engage with international delegates in attendance.

  • Specific Eligibility Criteria: Recipient must reside in Canada and be an Early Stage Professional. Early Stage Professionals are classified as students or professionals within ten years of their terminal degree or entry into the field of cell and gene therapy.

1 Available | Sponsor: ISCT Asia Regional Executive Committee

Recognizes the highest scoring abstract submitted by a presenter residing in Asia. 

  • Specific Eligibility Criteria: Recipient must reside in Asia.

1 Available | Sponsor: ISCT South & Central America Regional Executive Committee

The Top Scoring South & Central America Early Stage Professional Abstract Award recognizes outstanding contributions in CGT research within the South and Central America region. This award serves as a platform to acknowledge and promote the exceptional work of individuals who are making noteworthy strides within the dynamic landscapes of the South and Central America region.

  • Specific Eligibility Criteria: The recipient must reside in South & Central America and be an Early Stage Professional. Early Stage Professionals are classified as students or professionals within ten years of their terminal degree or entry into the field of cell and gene therapy.

1 Award of $1,000
2 Awards of $500

Sponsor: ISCT

The iPSC Abstract Awards are designed to recognize outstanding abstracts related to induced Pluripotent Stem Cells (iPSC) research. iPSCs have emerged as an area of immense potential in disease modeling, drug discovery, and therapeutics, and this award aims to highlight and support innovative contributions in this growing clinical field.

  • Specific Eligibility Criteria: Abstract must have been submitted in 'iPSC' abstract category.

1 Award of $1,000
2 Awards of $500

Sponsor: ISCT Stem Cell Engineering Committee

The Stem Cell Engineering Abstract Awards aim to recognize outstanding contributions in the field of stem cell engineering. These awards are designed to highlight innovative and impactful research in the application of engineering principles to the study, manipulation, and application of stem cells. The awarded abstracts should demonstrate significant advancements, novel approaches, or breakthroughs that contribute to the progress of stem cell research and its applications.

  • Specific Eligibility Criteria: None.

1 Award of $1,500

Sponsor: BioCanRx

The Highest Scoring Abstract in Immunotherapy for the Treatment of Cancer recognizes research in the field of cancer immunotherapies. This award is designed to support and promote advancements in the translation, manufacture, and adoption of cancer immunotherapies, with the goal of transforming all cancers into curable diseases.

  • Specific Eligibility Criteria: Abstract must have been submitted in “Immunotherapy (CAR-T, T Reg, NK Cells, etc.)” abstract category with focus on cancer treatment.

1 Award of $1,500

Sponsor: Stem Cell Network

Recognizing the breadth and depth of Canadian research, this award is presented to an outstanding Canadian researcher, highlighting Canada’s leadership in the cell and gene therapy space.

  • Specific Eligibility Criteria: Recipient must reside in Canada.

PUBLICATION AND FEES

Accepted abstracts will be published in a supplemental version of Cytotherapy, the official journal of ISCT.

There are no fees associated with submitting an abstract.  Those presenting abstracts will be responsible for their own registration expenses.  


Avoidance of Marketing or Promotion
ISCT requests that presenters avoid the use of trade names and logos for drugs, devices and/or instrumentation in these scientific sessions and to use generic names, where possible. Presentation content will be well-balanced, will be based on generally accepted scientific principles and methods, and will not promote a commercial interest.

GUIDELINES AND POLICIES

  • To qualify for submission under the late-breaking abstract category, abstracts must contain novel late-breaking data not available during initial submission period.
  • The abstract body cannot exceed 2500 characters, exclusive of the title, author block, images, and tables
  • Note that spaces count as characters.
  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will NOT be accepted by email, mail, or fax.
  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn from publication no later than March 12, 2024. If not withdrawn by this deadline, All accepted abstracts will be published in the final program and abstract supplement.
  • Abstract presenters MUST be registered for the meeting. For those requiring acceptance notifications before registering, ISCT 2024 will allow up to two weeks after acceptance for these individuals to register.
  • Abstracts submitted to the ISCT 2024 Annual Meeting are embargoed from the time of submission.
  • For the abstract to be eligible for presentation at the ISCT 2024 Annual Meeting, information contained within, as well as additional data and information to be presented about the content, may not be published elsewhere or made public before the abstract has been published/presented at the ISCT 2024 Annual Meeting.
  • Authors must notify ISCT if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the ISCT 2024 Annual Meeting. Publication before the meeting may result in the abstract being removed from the conference.
  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT from presentation at the ISCT 2024 Annual Meeting and from publication in the abstract supplement.

*An embargo means that information from any abstract or presentation may not be announced,
publicized, or distributed before the embargo date and time.

ISCT generally does not accept encore abstracts unless there are substantial data updates. However, exceptions may be granted upon written request to vanessaho@isctglobal.org, provided your request includes a clear justification for the encore abstract (e.g. if the ISCT audience significantly differs from the initial presentation).

* An encore abstract is the resubmission of an original abstract that has previously been presented at another conference